GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Stromacel PROT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Stromacel — daily PROT Delayed
Market value
$655
Last close × shares
Volume
66.2k
Shares, 30 Oct 2026

About Stromacel

Its shares trade under the ticker PROT. It has been listed since 31 July 1997. In the fiscal year to 31 December 2011, it reported revenue of $26,004 and a net loss of $1.4m. At that date it held total assets of $3.3m and shareholders' equity of −$3.7m.

Proteonomix, Inc. is a biotechnology company, which engages in the discovery and development of stem cell therapeutic and cosmeceutical products. The company is headquartered in Mountainside, New Jersey. The firm is a subsidiary of Proteonomix Inc. The company offers technology in the field of cellular medicine to international clients. The firm intends to conduct phased human studies of its cellular materials in application to the treatment of cardiac and other diseases.

Figures and description from our data supplier, not checked against the company's own report.

More about Stromacel →

Latest on Stromacel

Our reporting

We have not reported on Stromacel yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Stromacel's ticker?

Stromacel trades as PROT on its US listing, under ISIN US74371C2089.

What was Stromacel's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.